Multiplex Assays Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type (Cell-based Multiplex Assays, Protein Multiplex Assays, and Nucleic Acid Multiplex Assays), End-user (Hospital & Clinics, Research Institutions, Pharmaceutical & Biotechnology Companies, and Diagnostic Laboratories), and Region Forecast 2020-2031

Multiplex assay market size was valued at US$ 3.7 billion in 2024 and is expected to reach US$ 6.0 billion by 2031, growing at a significant CAGR of 7.1% from 2025-2031. The factors that contribute to the growth of the market, are the increase in the prevalence of chronic & infectious diseases such as respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Also, the covid-19 impacted market growth raising awareness of early diagnosis, and advantages over the singleplex & traditional assay, as multiplex assay is used to measure the multiple biomarkers to tailor the treatment for personalized medicine, and detection of multiple pathogens in an automated process, which became more efficient & cost-effective. Further, demand for multiplex assay for R&D from research institutions, and pharmaceutical & biotechnology companies, is expected to boost market growth over the forecast period. Despite the promising growth prospects, the market also faces certain challenges with limited resources like high investment costs, lack of skilled personnel for data analysis, and regulatory hurdles.

Key Developments

• In February 2024, Luminex Corporation launched the xMAP® UltraPlex™ II Multiplex Bead Array System, which is designed for high-throughput multiplex assays.
• In January 2024, Qiagen announced the opening of a new application center in Research Triangle Park, North Carolina, which will focus on developing and supporting next-generation sequencing (NGS) and multiplex assay technologies.